A Prospective, Multicentral, Open-label, Randomized, Controlled, Phase III Clinical Trial to Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Oct 2018
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms CAPITAL
- 23 Oct 2016 Planned primary completion date changed from 1 Jun 2016 to 1 Nov 2016.
- 23 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 25 Feb 2013 New trial record